Source: University of Mayland Medical Center
Also listed as: CoQ10; Ubiquinone
Coenzyme Q10 (CoQ10) is a compound found naturally in the
energy-producing center of the cell known as the mitochondria. CoQ10 is
involved in the making of an important molecule known as ATP. ATP
serves as the cell's major energy source and drives a number of
biological processes including muscle contraction and the production of
protein. CoQ10 also works as an antioxidant.
Antioxidants are substances that scavenge free radicals, damaging
compounds in the body that alter cell membranes, tamper with DNA, and
even cause cell death. Free radicals occur naturally in the body, but
environmental toxins (including ultraviolet light, radiation, cigarette
smoking, and air pollution) can also increase the number of these
damaging particles. Free radicals are believed to contribute to the
aging process as well as the development of a number of health problems
including heart disease and cancer. Antioxidants such as CoQ10 can
neutralize free radicals and may reduce or even help prevent some of
the damage they cause.
CoQ10 boosts energy, enhances the immune system, and acts as an
antioxidant. A growing body of research suggests that using coenzyme
Q10 supplements alone or in combination with other drug therapies and
nutritional supplements may help prevent or treat some of the following
conditions:
Heart Disease
Researchers believe that the beneficial effect of CoQ10 in the
prevention and treatment of heart disease is due to its ability to
improve energy production in cells, inhibit blood clot formation, and
act as an antioxidant. One important study, for example, found that
people who received daily CoQ10 supplements within 3 days of a heart
attack were significantly less likely to experience subsequent heart
attacks and chest pain. In addition, these same patients were less
likely to die of heart disease than those who did not receive the
supplements.
Congestive Heart Failure (CHF)
Levels of CoQ10 are low in people with CHF, a debilitating disease
that occurs when the heart is not able to pump blood effectively. This
can cause blood to pool in parts of the body such as the lungs and
legs. Information from many research studies suggests that CoQ10
supplements help reduce swelling in the legs, enhance breathing by
reducing fluid in the lungs, and increase exercise capacity in people
with CHF. Not all studies agree, however. As a result, some experts
conclude that CoQ10 supplements do not contribute any benefit to the
usual conventional treatment for CHF. More conclusive research will
help resolve the debate.
High Blood Pressure
Several studies involving small numbers of people suggest that CoQ10
may lower blood pressure. However, it may take 4 to 12 weeks before any
beneficial effect is observed. More research with greater numbers of
people is needed to assess the value of CoQ10 in the treatment of high
blood pressure.
High Cholesterol
Levels of CoQ10 tend to be lower in people with high cholesterol
compared to healthy individuals of the same age. In addition, certain
cholesterol-lowering drugs called statins (such as atorvastatin,
cerivastatin, lovastatin, pravastatin, simvastatin) appear to deplete
natural levels of CoQ10 in the body. Taking CoQ10 supplements can
correct the deficiency caused by statin medications without affecting
the medication's positive effects on cholesterol levels.
Diabetes
CoQ10 supplements may improve heart health and blood sugar and help
manage high cholesterol and high blood pressure in individuals with
diabetes. (High blood pressure, high cholesterol, and heart disease are
all common problems associated with diabetes). Despite some concern
that CoQ10 may cause a sudden and dramatic drop in blood sugar (called
hypoglycemia), two recent studies of people with diabetes given CoQ10
two times per day showed no hypoglycemic response. The safest bet if
you have diabetes is to talk to your doctor or registered dietitian
about the possible use of CoQ10.
Heart Damage caused by Chemotherapy
Several studies suggest that CoQ10 may help prevent heart damage
caused by certain chemotherapy drugs (namely adriamycin or other
athracycline medications). More scientific studies are needed to
further evaluate the effectiveness of CoQ10 in preventing heart damage
in cancer patients undergoing chemotherapy.
Heart Surgery
Research indicates that introducing CoQ10 prior to heart surgery,
including bypass surgery and heart transplantation, can reduce damage
caused by free radicals, strengthen heart function, and lower the
incidence of irregular heart beat (arrhythmias) during the recovery
phase.
Breast Cancer
Studies of women with breast cancer suggest that CoQ10 supplements
(in addition to conventional treatment and a nutritional regimen
including other antioxidants and essential fatty acids) may shrink
tumors, reduce pain associated with the condition, and cause partial
remission in some individuals. It is important to recognize that the
beneficial effects these women experienced cannot be attributed to
CoQ10 alone. Additional antioxidants used in these studies include
vitamins C, E, and selenium.
Periodontal (gum) Disease
Gum disease is a widespread problem that is associated with
swelling, bleeding, pain, and redness of the gums. Studies have shown
that people with gum disease tend to have low levels of CoQ10 in their
gums. In a few studies involving small numbers of subjects, CoQ10
supplements caused faster healing and tissue repair. Additional studies
are needed to evaluate the effectiveness of CoQ10 when used together
with traditional therapy for periodontal disease.
Other
Preliminary studies also suggest that CoQ10 may:
- Improve immune function in individuals with immune deficiencies
(such as AIDS) and chronic infections (such as yeast and other viral
infections)
- Increase sperm motility leading to enhanced fertility
- Be used as part of the treatment for Alzheimer's disease
- Reduce damage from stroke
- Boost athletic performance
- Enhance physical activity in people with fatigue syndromes
- Improve exercise tolerance in individuals with muscular dystrophy
Research in all of these areas is underway to determine whether CoQ10
can be safety and effectively used in people with these health
problems.
Primary dietary sources of CoQ10 include oily fish, organ meats such as
liver, and whole grains. Most individuals obtain sufficient amounts of
CoQ10 through a balanced diet, but supplementation may be useful for
individuals with particular health conditions (see Uses section) or
those taking certain medications (see Interactions section).
Coenzyme Q10 is available as a supplement in several forms, including
softgel capsules, oral spray, hardshell capsules, and tablets.
Pediatric
There are no known scientific reports on the pediatric use of CoQ10.
Therefore, use of CoQ10 supplements is not currently recommended for
children.
Adult
The general recommended dose for CoQ10 supplementation is 30 to 60
mg daily. Higher doses have been used in studies and may be recommended
for the following conditions:
- Congestive heart failure: 50 to 150 mg a day
- High blood pressure: 50 to 150 mg a day
- To enhance athletic performance: 60 mg a day for 4 to 8 weeks
- Heart attack: 120 mg a day for 28 days after the heart attack
- Breast cancer: 400 mg per day for potential prevention and treatment
Coenzyme Q10 is fat-soluble so should be taken with a meal containing fat for optimal absorption.
Because of the potential for side effects and interactions with
medications, dietary supplements should be taken only under the
supervision of a knowledgeable healthcare provider.
Coenzyme Q10 appears to be generally safe with no significant side
effects, except occasional stomach upset. However, the safety of CoQ10
supplementation during pregnancy and breastfeeding is unknown and,
therefore, should not be used during that time until more information
is available.
If you are currently being treated with any of the following
medications, you should not use CoQ10 without first talking to your
healthcare provider.
Daunorubicin and Doxorubicin
Coenzyme Q10 may help to reduce the toxic effects on the heart
caused by daunorubicin and doxorubicin, two chemotherapy medications
that are commonly used to treat a variety of cancers.
Blood Pressure Medications
In a study of individuals taking blood pressure medications (including
diltiazem, metoprolol, enalapril, and nitrate), CoQ10 supplementation
allowed the individuals to take lower dosages of these drugs. This
suggests that CoQ10 may enhance the effectiveness of certain blood
pressure medications, but more research is needed to verify these
results.
Warfarin
There have been reports that coenzyme Q10 may decrease the
effectiveness of blood-thinning medications such as warfarin, leading
to the need for increased doses. Therefore, given that this medication
must be monitored very closely for maintenance of appropriate levels
and steady blood thinning, CoQ10 should only be used with warfarin
under careful supervision by your healthcare provider.
Timolol
CoQ10 supplementation may reduce the heart-related side effects of
timolol drops, a beta-blocker medication used to treat glaucoma,
without decreasing the effectiveness of the medication.
Other
Medications that can lower the levels of coenzyme Q10 in the body
include statins for cholesterol (atorvastatin, cerivastatin,
lovastatin, pravastatin, simvastatin), fibric acid derivatives for
cholesterol (specifically, gemfibrozil), beta-blockers for high blood
pressure (such as atenolol, labetolol, metoprolol, and propranolol),
and tricyclic antidepressant medications (including amitriptyline,
amoxapine, clomipramine, desipramine, doxepin, imipramine,
nortriptyline, protriptyline, and trimipramine).
Aberg F, Appelkvist EL, Broijersen A, et al. Gemfibrozil-induced
decrease in serum ubiquinone and alpha- and gamma-tocopherol levels in
men with combined hyperlipidaemia. Eur J Clin Invest . 1998;28:235-242.
Al-Hasso. Coenzyme Q10: a review. Hosp Pharm . 2001;36(1):51-66.
Alleva R, Scaraarmucci A, Mantera F, Bompandre S, Leoni L, Linarro GP.
The protective role of ubiquinol—10 against formation of lipid
hydroperoxdes in human seminal fluids. Mol Asp Med . 1997;18:221-228.
Baggio E, Gandini R, Plancher AC, Passeri M, Carmosino G. Italian
multicenter study on the safety and efficacy of coenzyme Q10 as
adjunctive therapy in heart failure. CoQ10 Drug Surveillance
Investigators. Mol Aspects Med . 1994;15(Suppl):s287-294.
Chello M, Mastroroberto P, Romano R, et al. Protection by coenzyme Q10
from myocardial reperfusion injury during coronary artery bypass
grafting. Ann Thorac Surg . 1994;58(5):1427-1432.
Chopra RK, Goldman R, Sinatra ST, Bhagavan HN. Relative bioavailability of coenzyme Q10 formulations in human subjects. Int J Vitam Nutr Res . 1998;68:109-113.
de Bustos F, Molina JA, Jimenez-Jimenz FJ, Garcia-Redondo A,
Gomez-Escalonilla C, Porta-Etessam J, et al. Serum levels of coenzyme
Q10 in patients with Alzheimer's disease. J Neural Transm . 2000;107(2):233-239.
Eriksson JG. The effects of coenzyme Q10 administration on metabolic control in patients with type 2 diabetes mellitus. Biofactors . 1999;9(2-4):315-318.
Folkers K, Langsjoen P, Nara Y, et al. Biochemical deficiencies of coenzyme Q10 in HIV infection and exploratory treatment. Biochem Biophys Res Commun . 1988;153:888-896.
Hanioka T, Tanaka M, Ojima M, Shizukuishi S, Folkers K. Effect of topical application of coenzyme Q10 on adult periodontitis. Mol Aspects Med. 1994;15 Suppl:s241-248.
Heck AM, DeWitt BA, Lukes AL. Potential interactions between alternative therapies and warfarin. Am J Health-System Pharm . 2000;57(13):1221-1227.
Henriksen J, Andersen CB, Hother-Nielsen O, Vaag A, Mortensen SA,
Beck-Nielsen H. Impact of ubiquinone (coenzyme Q10) treatment on
glycaemic control, insulin requirement and well-being in patients with
type 1 diabetes mellitus. Diabet Med . 1999; 16:312-8.
Human JA, Ubbink JB, Jerling JJ, et al. The effect of simvastatin on
the plasma antioxidant concentrations in patients with
hypercholesterolemia. Clin Chim Acta . 1997;263(1):67-77.
Iarussi D, Auricchio U, Agretto A, et al. Protective effect of coenzyme
Q on anthracylines cardiotoxicity: control study in children with acute
lymphoblastic leukemia and non-hodgkin lymphoma. Molec Aspects Med . 1994;15(Suppl):S207-S212.
Jolliet P, Simon N, Barre J, et al. Plasma coenzyme Q10 concentrations
in breast cancer: prognosis and therapeutic consequences. Int J Clin Pharmacol Ther . 1998;36:506-509.
Judy WV, Hall JH, Dugan W, et al. Coenzyme Q10 reduction of adriamycin cardiotoxicity. In: Folkes K, Yamamura Y, Eds. Biomedical and clinical aspects of coenzyme Q10 , Vol. 4. Amsterdam: Elsevier. 1984:231-241.
Kendler BS. Recent nutritional approaches to prevention and therpy of cardiovascular disease. Prog Cardiovasc Nurs . 1997;12(3):3-23.
Khatta M, Alexander BS, Krichten CM, Fisher ML, Freudenberger R,
Robinson SW et al. The effect of conenzyme Q10 in patients with
congestive heart failure. Ann Int Med . 2000;132(8):636-640.
Landbo C, Almdal TP. Drug interaction between warfarin and coenzyme Q10. Ugeskrift for Laeger . 1998;160(22):3226-3227.
Langsjoen P, Langsjoen A. Overview of the use of CoQ10 in cardiovascular disease. BioFactors . 1999;9:273-284.
Langsjoen P, Langsjoen A, Willis R, Folkers K. Treatment of Essential Hypertension with Coenzyme Q10. Molec Aspects Med . 1994;15:s265-s272.
Lewin A, Loron M. The effect of coenzyme Q10 on sperm mobility and function. Mol Asp Med . 1997;18:213-219.
Lockwood K, Moesgaard S, Folkers K. Partial and complete regression of
breast cancer in patients in relation to dosage of coenzyme Q10. Biochem Biophys Res Commun . 1994;199(3):1504-1508.
Lockwood K, Moesgaard S, Hanioka T, Folkers K. Apparent partial
remission of breast cancer in "high risk" patients supplemented with
nutritional antioxidants, essential fatty acids, and coenzyme Q10. Mol AspMed . 1994;15 Suppl:s231-s240.
Lockwood K, Moesgaard S, Yamamoto T, Folkers K. Progress in therapy of
breast cancer with vitamin Q10 and the regression of metastases. Biochem Biophys Res Commun. 1995;212(1):172-177.
Marz W, Wieland H. HMG-CoA reducatse inhibition: anti-inflammatory effects beyond lipid lowering. Herz . 2000;25(6):117-25.
Matthews RT, Yang L, Browne S, Baik M, Beal MF. Coenzyme Q10
administration increases brain mitochondrial concentrations and exerts
neuroprotective effects. Proc Natl Acad Sci USA. July 21, 1998; 95:8892-8897.
McCarty MF. Coenzyme Q versus hypertension: does CoQ decrease endothelial superoxide generation? Med Hypotheses. 1999;53:300-304.
McCarty MF. Toward practical prevention of type 2 diabetes. Med Hypotheses. 2000;54(5):786-793.
Miyake Y, Shouza A, Nishikawa M, Yonemoto T, Shimizu H, Omoto S,
Hayakawa T, Inada M. Effect of treatment with 3-hydroxy-3methylglutaryl
coenzyme A reductase inhibitors on serum coenzyme Q10 in diabetic
patients. Arzneimittelforschung . 1999;49(4):324-329.
Mortensen SA, Leth A, Agner E, Rohde M. Dose-related decrease of serum
coenzyme Q10 during treatment with HMG-CoA reductase inhibitors. Mol Aspects Med . 1997;18Suppl:S137-S144.
Musumeci O, Naini A, Slonim AE, Skavin N, Hadjigeorgiou GL, Krawiecki
N, et al. Familial cerebellar ataxia with muscle coenzyme Q10
deficiency. Neurol . 2001;56(7):849-855.
Niibori K, Yokoyama H, Crestanello JA, Whitman GJ. Acute administration
of liposomal coenzyme Q10 increases myocardial tissue levels and
improves tolerance to ischemia reperfusion injury. J Surg Res . 1998;79:141-145.
Ostrowski RP. Effect of coenzyme Q(10) on biochemical and morphological changes in experimental ischemia in the rat brain. Brain Res Bull . 2000;53(4):399-407.
Ott BR, Owens NJ. Complementary and alternative medicines for Alzheimer's disease. J Geriatr Psychiatry Neurol . 1998;11:163-173.
Overvad K, Diamant B, Holm L, Holmer G, Mortensen SA, Stender S. Review coenzyme Q10 in health and disease. Eur J Clin Nut . 1999;53:764-770.
Raitakari OT, McCredie RJ, Witting P, Griffiths KA, Letter J, Sullivan
D, Stocker R, Celermajer DS. Coenzyme Q improves LDL resistance to ex
vivo oxidation but does not enhance endothelial function in
hypercholesterolemic young adults. Free Radic Biol Med . 2000;28(7):1100-1105.
Serebruany VL, Ordonez JV, Herzog WR, et al. Dietary coenzyme Q10
supplementation alters platelet size and inhibits human vitronectin
(CD51/CD61) receptor expression . J Cardiovasc Pharmacol. 1997;29:16-22.
Shils ME, Olson JA, Shike M, Ross AC. Modern Nutrition in Health and Disease . 9th ed. Baltimore, Md: Williams & Wilkins; 1999:90-92: 1377-1378.
Shinozawa S, Kawasaki H, Gomita Y. [Effect of biological membrane
stabilizing drugs (coenzyme Q10, dextran sulfate and reduced
glutathione) on adriamycin (doxorubicin)-induced toxicity and
microsomal lipid peroxidation in mice]. Gan To Kagaku Ryoho . 1996;23(1):93-98.
Sinclair S. Male infertility: nutritional and environmental considerations. Alt Med Rev . 2000;5(1):28-37.
Singh RB, Niaz MA, Rastogi SS, Shukla PK, Thakur AS. Effect of
hydrosoluble coenzyme Q10 on blood pressures and insulin resistance in
hypertensive patients with coronary artery disease. J Hum Hypertens . 1999;13(3):203-208.
Singh RB, Wander GS, Rastogi A, et al. Randomized, double-blind
placebo-controlled trial of coenzyme Q10 in patients with acute
myocardial infarction. Cardiovasc Drugs Ther. 1998;12:347-353.
Spigset O. Reduced effect of warfarin caused by ubidecarenone. Lancet . 1994;344:1372-1373.
Takahashi N, Iwasaka T, Sugiura T, et al. Effect of coenzyme Q10 on hemodynamic response to ocular timolol. J Cardiovasc Pharmacol . 1989;14:462-468.
Torkos S. Drug-nutrient interactions: A focus on cholesterol-lowering agents. Int J Integrative Med . 2000;2(3):9-13.
Tsukahara Y, Wakatsuki A, Okatani Y. Antioxidant role of endogenaous
coenzyme Q against the iscemic and reperfusion-induced lipid
peroxidation in fetal rat brain. Acta Obstet Gynecol Scand . 1999;78(8):669-674.
Werbach M. Foundations of Nutritional Medicine . Tarzana, Calif: Third Line Press, Inc.; 1997:209.
Wilkinson EG, Arnold RM, Folkers K. Treatment of periodontal and other
soft tissue diseases in the oral cavity with coenzyme Q10. In: Folker
K, Yamamura Y, eds. Biomedical and Clinical Aspects of Coenzyme Q10 , Vol 1. Elsevier/North-Holland Biomedical Press;Amsterdam, 1977:251-265.
Witte KK, Clark AL, Cleland JG. Chronic heart failure and micronutrients. J Am Coll Cardiol . 2001;37(7):1765-1774.
Zhou Q, Chan E. Accuracy of repeated blood sampling in rats: A new
technique applied in pharmacokinetic/pharmacodynamic studies of the
interaction between warfarin and Co-enzyme Q10. J Pharmacol Toxicol Methods . 1998;40(4):191-199.
- Review Date:
4/1/2002
- Reviewed By: Participants in the review process include:
Jacqueline A. Hart, MD, Department of Internal Medicine,
Newton-Wellesley Hospital, Harvard University and Senior Medical Editor
Integrative Medicine, Boston, MA; Gary Kracoff, RPh (Pediatric Dosing
section February 2001), Johnson Drugs, Natick, Ma; Steven Ottariono,
RPh (Pediatric Dosing section February 2001), Veteran's Administrative
Hospital, Londonderry, NH; Margie Ullmann-Weil, MS, RD, specializing in
combination of complementary and traditional nutritional therapy,
Boston, MA. All interaction sections have also been reviewed by a team
of experts including Joseph Lamb, MD (July 2000), The Integrative
Medicine Works, Alexandria, VA;Enrico Liva, ND, RPh (August 2000),
Vital Nutrients, Middletown, CT; Brian T Sanderoff, PD, BS in Pharmacy
(March 2000), Clinical Assistant Professor, University of Mayland
School of Pharmacy; President, Your Prescription for Health, Owings
Mills, MD; Ira Zunin, MD, MPH, MBA (July 2000), President and Chairman,
Hawaii State Consortium for Integrative Medicine, Honolulu, HI.
Statements made on this site has not been evaluated by the Food and Drug Administration.Energyade is not intended to diagnose, treat or cure or prevent a disease. Information on this site provided for eductional purposes only. The information provided herein should not be used during any
medical emergency or for the diagnosis or treatment of any medical
condition or disease. A licensed medical professional should be consulted for
diagnosis and treatment of any and all medical conditions. Call 911 for
all medical emergencies. Links to other sites are provided for
information purposes only -- they do not constitute endorsements of those other
sites.
|